Parkinson Disease, Postencephalitic (physiopathology) < Parkinson Disease, Secondary (chemically induced) < Parkinson Disease, Secondary (classification)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 79.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000023 (1999)	E. Bezard [France] ; T. Boraud ; B. Bioulac ; C E Gross	Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms.
000055 (1999)	D. Guehl [France] ; E. Bezard ; S. Dovero ; T. Boraud ; B. Bioulac ; C. Gross	Trichloroethylene and parkinsonism: a human and experimental observation.
000088 (1999)	V. Ben [France] ; O. Blin ; B. Bruguerolle	Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions.
000092 (2000)	C. Périer [France] ; M. Vila ; J. Féger ; Yves Agid [France] ; E C Hirsch	Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats.
000094 (2000)	A. Boireau [France] ; P. Dubedat ; F. Bordier ; A. Imperato ; S. Moussaoui	The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP(+) accumulation.
000118 (2000)	I. Ghorayeb [France] ; P O Fernagut ; I. Aubert ; E. Bezard ; Werner Poewe [Autriche] ; G K Wenning ; F. Tison	Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration.
000125 (2000)	R. Bordet [France] ; S. Ridray ; J C Schwartz ; P. Sokoloff	Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
000133 (2000)	E. Bezard [France] ; M. Jaber ; F. Gonon ; A. Boireau ; B. Bloch ; C E Gross	Adaptive changes in the nigrostriatal pathway in response to increased 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration in the mouse.
000136 (2000)	V. Ben [France] ; B. Bruguerolle	Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study.
000156 (2000)	C. Jan [France] ; C. François ; D. Tandé ; J. Yelnik ; L. Tremblay ; Yves Agid [France] ; E. Hirsch	Dopaminergic innervation of the pallidum in the normal state, in MPTP-treated monkeys and in parkinsonian patients.
000170 (????)	K. Masmoudi [France] ; V. Gras-Champel ; I. Bonnet ; M. Pannier ; H. Masson ; A. Rosa ; M. Andréjak	[Dementia and extrapyramidal problems caused by long-term valproic acid].
000179 (2001)	H. Turmel [France] ; A. Hartmann ; K. Parain ; A. Douhou ; A. Srinivasan ; Yves Agid [France] ; E C Hirsch	Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
000196 (2001)	T. Poyot [France] ; F. Condé ; M C Grégoire ; V. Frouin ; C. Coulon ; C. Fuseau ; F. Hinnen ; F. Dollé ; P. Hantraye ; M. Bottlaender	Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
000217 (2001)	O K Hassani [France] ; M. Mouroux ; G A Bohme ; J M Stutzmann ; J. Féger	Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain.
000223 (2002)	Maria C. Obinu [France] ; Michel Reibaud ; Véronique Blanchard ; Saliha Moussaoui ; Assunta Imperato	Neuroprotective effect of riluzole in a primate model of Parkinson's disease: behavioral and histological evidence.
000352 (2003)	Caroline Prunier [France] ; Erwan Bézard ; Jérôme Montharu ; Marina Mantzarides ; Jean-Claude Besnard ; Jean-Louis Baulieu ; Christian Gross ; Denis Guilloteau ; Sylvie Chalon	Presymptomatic diagnosis of experimental Parkinsonism with 123I-PE2I SPECT.
000373 (1992)	A. Benazzouz [France] ; C. Gross ; J. Dupont ; B. Bioulac	MPTP induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies.
000429 (2004)	Christophe Jollivet [France] ; Anne Aubert-Pouessel ; Anne Clavreul ; Marie-Claire Venier-Julienne ; Claudia N. Montero-Menei ; Jean-Pierre Benoit ; Philippe Menei	Long-term effect of intra-striatal glial cell line-derived neurotrophic factor-releasing microspheres in a partial rat model of Parkinson's disease.
000430 (2004)	Roberto Coccurello [France] ; Nathalie Breysse ; Marianne Amalric	Simultaneous blockade of adenosine A2A and metabotropic glutamate mGlu5 receptors increase their efficacy in reversing Parkinsonian deficits in rats.
000436 (2004)	Vincent Paillé [France] ; Philippe Brachet ; Philippe Damier	Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease.
000444 (2004)		Extrapyramidal reactions to SSRI antidepressant + neuroleptic combinations.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Parkinson Disease, Secondary (chemically induced)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Parkinson Disease, Secondary (chemically induced)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease, Secondary (chemically induced)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024